HK Stock MarketDetailed Quotes

02297 RAINMED-B

Watchlist
  • 0.165
  • 0.0000.00%
Trading Apr 25 09:00 CST
192.69MMarket Cap-1513P/E (TTM)

RAINMED-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(FY)Dec 31, 2019
Turnover
-12.42%73.22M
-2.94%50.37M
2.96%83.6M
--51.9M
1,231.79%81.2M
2,239.32%64.92M
585.06%6.1M
--2.78M
--890K
Operating income
-12.42%73.22M
-2.94%50.37M
2.96%83.6M
51.9M
1,231.79%81.2M
2,239.32%64.92M
585.06%6.1M
2.78M
890K
Cost of sales
-79.00%-24.67M
-85.59%-13.12M
-13.26%-13.78M
---7.07M
-1,353.64%-12.17M
-2,739.47%-9.57M
-206.59%-837K
---337K
---273K
Operating expenses
-79.00%-24.67M
-85.59%-13.12M
-13.26%-13.78M
-7.07M
-1,353.64%-12.17M
-2,739.47%-9.57M
-206.59%-837K
-337K
-273K
Gross profit
-30.46%48.55M
-16.90%37.25M
1.15%69.82M
44.83M
1,212.40%69.03M
2,170.18%55.35M
752.51%5.26M
2.44M
617K
Selling expenses
-6.17%-70.87M
-18.33%-38.4M
4.81%-66.75M
---32.45M
-290.99%-70.12M
-477.25%-54.16M
-210.33%-17.93M
---9.38M
---5.78M
Administrative expenses
31.67%-74.7M
20.85%-37.32M
5.11%-109.32M
---47.15M
-881.40%-115.21M
-976.42%-74.74M
-54.08%-11.74M
---6.94M
---7.62M
Research and development expenses
6.44%-41.33M
19.08%-22.62M
-63.78%-44.17M
---27.95M
-128.06%-26.97M
-80.07%-14.81M
-39.10%-11.83M
---8.23M
---8.5M
Impairment and provision
-39.13%-96K
---57K
-1,050.00%-69K
----
-108.57%-6K
-110.71%-6K
190.91%70K
--56K
---77K
-Other impairment is provision
-39.13%-96K
---57K
-1,050.00%-69K
----
-108.57%-6K
-110.71%-6K
190.91%70K
--56K
---77K
Special items of operating profit
41.80%10.25M
-14.20%5.8M
1,369.51%7.23M
--6.76M
-87.09%492K
-92.68%242K
60.49%3.81M
--3.31M
--2.37M
Operating profit
10.52%-128.18M
1.11%-55.35M
-0.33%-143.25M
-55.97M
-341.23%-142.78M
-370.00%-88.13M
-70.44%-32.36M
-18.75M
-18.99M
Financing income
254.94%12.41M
478.22%7.54M
92.99%3.5M
--1.3M
5,226.47%1.81M
5,232.00%1.33M
100.00%34K
--25K
--17K
Financing cost
-72.24%-1.31M
-87.77%-706K
80.30%-760K
---376K
-907.31%-3.86M
-1,687.19%-3.63M
-95.41%-383K
---203K
---196K
Special items of earning before tax
----
----
-145.19%-1.21B
---1.17B
-317.64%-493.86M
-340.73%-323.64M
-305.38%-118.25M
---73.43M
---29.17M
Earning before tax
91.34%-117.09M
96.03%-48.51M
-111.59%-1.35B
-1.22B
-323.09%-638.69M
-348.30%-414.06M
-212.32%-150.96M
-92.36M
-48.34M
Tax
-99.60%22K
-95.52%499K
8.07%5.45M
--11.13M
-11.80%5.04M
42.34%4.06M
78.63%5.72M
--2.85M
--3.2M
After-tax profit from continuing operations
91.30%-117.07M
96.03%-48.02M
-112.42%-1.35B
-1.21B
-336.28%-633.65M
-358.05%-410.01M
-221.80%-145.24M
-89.51M
-45.13M
Earning after tax
91.30%-117.07M
96.03%-48.02M
-112.42%-1.35B
-1.21B
-336.28%-633.65M
-358.05%-410.01M
-221.80%-145.24M
-89.51M
-45.13M
Minority profit
---1.24M
---536K
----
----
---1K
---1K
----
----
---6K
Profit attributable to shareholders
91.39%-115.83M
96.08%-47.48M
-112.42%-1.35B
-1.21B
-336.27%-633.65M
-358.05%-410M
-221.84%-145.24M
-89.51M
-45.13M
Basic earnings per share
93.33%-0.1
97.87%-0.04
-51.52%-1.5
-1.88
92.42%-0.99
-296.27%-31.9
-221.67%-13.06
-8.05
-4.06
Diluted earnings per share
93.33%-0.1
97.87%-0.04
-51.52%-1.5
-1.88
92.42%-0.99
-296.27%-31.9
-221.67%-13.06
-8.05
-4.06
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
Xinyong Zhonghe (Hong Kong) Certified Public Accountants Limited
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(FY)Dec 31, 2019
Turnover -12.42%73.22M-2.94%50.37M2.96%83.6M--51.9M1,231.79%81.2M2,239.32%64.92M585.06%6.1M--2.78M--890K
Operating income -12.42%73.22M-2.94%50.37M2.96%83.6M51.9M1,231.79%81.2M2,239.32%64.92M585.06%6.1M2.78M890K
Cost of sales -79.00%-24.67M-85.59%-13.12M-13.26%-13.78M---7.07M-1,353.64%-12.17M-2,739.47%-9.57M-206.59%-837K---337K---273K
Operating expenses -79.00%-24.67M-85.59%-13.12M-13.26%-13.78M-7.07M-1,353.64%-12.17M-2,739.47%-9.57M-206.59%-837K-337K-273K
Gross profit -30.46%48.55M-16.90%37.25M1.15%69.82M44.83M1,212.40%69.03M2,170.18%55.35M752.51%5.26M2.44M617K
Selling expenses -6.17%-70.87M-18.33%-38.4M4.81%-66.75M---32.45M-290.99%-70.12M-477.25%-54.16M-210.33%-17.93M---9.38M---5.78M
Administrative expenses 31.67%-74.7M20.85%-37.32M5.11%-109.32M---47.15M-881.40%-115.21M-976.42%-74.74M-54.08%-11.74M---6.94M---7.62M
Research and development expenses 6.44%-41.33M19.08%-22.62M-63.78%-44.17M---27.95M-128.06%-26.97M-80.07%-14.81M-39.10%-11.83M---8.23M---8.5M
Impairment and provision -39.13%-96K---57K-1,050.00%-69K-----108.57%-6K-110.71%-6K190.91%70K--56K---77K
-Other impairment is provision -39.13%-96K---57K-1,050.00%-69K-----108.57%-6K-110.71%-6K190.91%70K--56K---77K
Special items of operating profit 41.80%10.25M-14.20%5.8M1,369.51%7.23M--6.76M-87.09%492K-92.68%242K60.49%3.81M--3.31M--2.37M
Operating profit 10.52%-128.18M1.11%-55.35M-0.33%-143.25M-55.97M-341.23%-142.78M-370.00%-88.13M-70.44%-32.36M-18.75M-18.99M
Financing income 254.94%12.41M478.22%7.54M92.99%3.5M--1.3M5,226.47%1.81M5,232.00%1.33M100.00%34K--25K--17K
Financing cost -72.24%-1.31M-87.77%-706K80.30%-760K---376K-907.31%-3.86M-1,687.19%-3.63M-95.41%-383K---203K---196K
Special items of earning before tax ---------145.19%-1.21B---1.17B-317.64%-493.86M-340.73%-323.64M-305.38%-118.25M---73.43M---29.17M
Earning before tax 91.34%-117.09M96.03%-48.51M-111.59%-1.35B-1.22B-323.09%-638.69M-348.30%-414.06M-212.32%-150.96M-92.36M-48.34M
Tax -99.60%22K-95.52%499K8.07%5.45M--11.13M-11.80%5.04M42.34%4.06M78.63%5.72M--2.85M--3.2M
After-tax profit from continuing operations 91.30%-117.07M96.03%-48.02M-112.42%-1.35B-1.21B-336.28%-633.65M-358.05%-410.01M-221.80%-145.24M-89.51M-45.13M
Earning after tax 91.30%-117.07M96.03%-48.02M-112.42%-1.35B-1.21B-336.28%-633.65M-358.05%-410.01M-221.80%-145.24M-89.51M-45.13M
Minority profit ---1.24M---536K-----------1K---1K-----------6K
Profit attributable to shareholders 91.39%-115.83M96.08%-47.48M-112.42%-1.35B-1.21B-336.27%-633.65M-358.05%-410M-221.84%-145.24M-89.51M-45.13M
Basic earnings per share 93.33%-0.197.87%-0.04-51.52%-1.5-1.8892.42%-0.99-296.27%-31.9-221.67%-13.06-8.05-4.06
Diluted earnings per share 93.33%-0.197.87%-0.04-51.52%-1.5-1.8892.42%-0.99-296.27%-31.9-221.67%-13.06-8.05-4.06
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor Xinyong Zhonghe (Hong Kong) Certified Public Accountants Limited--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg